Related Experiment Video
Updated: Aug 14, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Epidemiology of invasive meningococcal disease in France in 2003
A Perrocheau1, M K Taha, D Levy-Bruhl
1Unité des Maladies à Prévention Vaccinale, Département des Maladies Infectieuses, Institut de Veille Sanitaire, Saint Maurice, France.
Abstract:
National surveillance of invasive meningococcal disease (IMD) is based on mandatory reporting. The case definition for surveillance notification was changed in mid-2002 to include cases without microbiological confirmation. The IMD alert detection system was enhanced in 2003 with daily reporting and weekly analysis by district, serogroup, and age. Evaluation of the exhaustivity of the surveillance with capture-recapture analysis allowed correcting for underreporting. In 2003, 803 cases were reported. After correction for under-reporting, the estimated incidence was 1.78 / 100,000. After excluding 'new' cases reported with new definition criteria, the 2002-2003 increase was 4%. Incidence decreased with age, with the highest values in infants less than 1 year (20/100,000), children aged between 1 and 2 years (11/100,000) and in teenagers of 17 years old(7/100,000). The overall case fatality rate was 12%. Fifty nine per cent of cases were due to serogroup B, 32% to C, 5% to W135, and 4% to Y and non-groupable meningococci. Patients with purpura fulminans treated with intravenous antibiotics before admission to hospital were shown to have lower fatality rates than those not treated. In 2001-2003, 5 situations required particular attention: two clusters of serogroup B IMD had set off mass prophylaxis, one outbreak due to a specific B IMD clonal complex with high case fatality rate, and two districts crossed the alert threshold for serogroup C IMD, 2/100,000, and mass vaccination was recommended.
Insights
National surveillance of invasive meningococcal disease (IMD) improved with enhanced reporting and analysis. Despite a 4% increase, IMD incidence decreased with age, with serogroup B being most common.
Area of Science:
- Epidemiology
- Infectious Disease Surveillance
- Public Health
Background:
- National surveillance of invasive meningococcal disease (IMD) relies on mandatory reporting.
- Changes to the case definition in mid-2002 expanded surveillance to include non-microbiologically confirmed cases.
- Enhancements to the IMD alert detection system in 2003 included daily reporting and weekly analysis.
Purpose of the Study:
- To evaluate the exhaustivity of IMD surveillance through capture-recapture analysis.
- To estimate the true incidence of IMD after correcting for underreporting.
- To analyze trends, age-specific incidence, serogroup distribution, and case fatality rates of IMD.
Main Methods:
- Capture-recapture analysis was employed to estimate underreporting.
- Surveillance data from 2003 were analyzed for case numbers, incidence, and demographics.
- Serogroup distribution and case fatality rates, including the impact of purpura fulminans and treatment, were assessed.
Main Results:
- In 2003, 803 IMD cases were reported, with an estimated incidence of 1.78/100,000 after correction for underreporting.
- A 4% increase in IMD was observed between 2002-2003 after excluding 'new' definition cases.
- Incidence was highest in infants (<1 year) and young children (1-2 years), decreasing with age. Serogroups B (59%) and C (32%) were predominant. Case fatality rate was 12%.
Conclusions:
- Enhanced surveillance and capture-recapture analysis provide a more accurate picture of IMD burden.
- Targeted interventions, including mass prophylaxis and vaccination, were implemented in response to specific outbreaks and alert thresholds.
- Early antibiotic treatment for purpura fulminans was associated with lower fatality rates.
Related Concept Videos
Bacterial Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Cryptococcal Meningitis
Viral Meningitis
Rocky Mountain Spotted Fever

